This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Search results

From Proteopedia

You searched for Ponatinib

Jump to: navigation, search

There is no page with the exact title "Ponatinib". The search results for "Ponatinib" are displayed below. You can create a page titled Ponatinib (by clicking on the red link).

For more information about searching Proteopedia, see Help.

To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.

Showing below up to 20 results starting with #1.


View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)

Article title matches

  1. Image:PONATINIB.jpg (22 bytes)
    1: Ponatinib bound to Abl
  2. Category:Ponatinib (40 bytes)
    1: List of pages with the keyword Ponatinib

Page text matches

  1. 3zos (4,059 bytes)
    2: ...ructure of the DDR1 kinase domain in complex with ponatinib==
    14: ...ated outside the ATP pocket. Whereas imatinib and ponatinib bind potently to both the DDR and ABL kinases, th...
  2. SandboxPKA (24,333 bytes)
    138: ==== Ponatinib (AP24534)====
    140: [[Image:PONATINIB.jpg|thumb|left|Ponatinib bound to Abl]]
    142: Ponatinib was identified using structure base drug design a...
    144: <scene name='SandboxPKA/Ponatinib_bound_to_abl/1'>Ponatinib bound to c-Abl kinase domain</scene>
    145: <scene name='52/521153/Ponatinib_bound_to_abl/2'>Ponatinib bound to c-Abl kinase domain</scene>
  3. Bcr-Abl and Imatinib (STI571 or Gleevec) (24,270 bytes)
    137: ==== Ponatinib (AP24534)====
    139: [[Image:PONATINIB.jpg|thumb|400px|left|Ponatinib bound to Abl]]
    141: Ponatinib was identified using structure base drug design a...
    143: <scene name='52/521153/Ponatinib_bound_to_abl/2'>Ponatinib bound to c-Abl kinase domain</scene>
  4. 3oxz (6,270 bytes)
    14: ...utations. The inhibitory mechanism exemplified by ponatinib may have broad relevance to designing inhibitors ...
    16: Structural Mechanism of the Pan-BCR-ABL Inhibitor Ponatinib (AP24534): Lessons for Overcoming Kinase Inhibito...
  5. 3oy3 (6,337 bytes)
    14: ...utations. The inhibitory mechanism exemplified by ponatinib may have broad relevance to designing inhibitors ...
    16: Structural Mechanism of the Pan-BCR-ABL Inhibitor Ponatinib (AP24534): Lessons for Overcoming Kinase Inhibito...
  6. Sandbox423 (4,126 bytes)
    16: ...onnor Walsh -- fibroblast growth factor receptor/ Ponatinib (cancer)(4uxq)
  7. Student Projects for UMass Chemistry 423 Spring 2016 (14,869 bytes)
    139: ...onnor Walsh -- fibroblast growth factor receptor/ Ponatinib (cancer)(4uxq)
  8. Sandbox Reserved 425 (9,939 bytes)
    5: =='''Fibroblast Growth Factor Receptor/Ponatinib (4uxq) <ref name="one">PMID: 25465127</ref>'''==
    9: ... load='4uxq' size='350' side='right' caption='The Ponatinib-FGFR complex is highly effective for treating CML...
    15: ...-ABL flipped out of its hydrophobic binding site. Ponatinib is the first of its kind to be able to inhibit th...
    17: Ponatinib's harmful side effects have caused it to fall und...
    21: ...secondary structure</scene>, FGFR in complex with Ponatinib consists of two domains, which is the characteris...
  9. Image:PONATINIB.jpg (22 bytes)
    1: Ponatinib bound to Abl
  10. 4bkj (4,048 bytes)
    14: ...ated outside the ATP pocket. Whereas imatinib and ponatinib bind potently to both the DDR and ABL kinases, th...
  11. 4c8b (4,866 bytes)
    2: ... the kinase domain of human RIPK2 in complex with ponatinib==
    14: ...ned the first crystal structure of RIPK2 bound to ponatinib, and identified an allosteric site for inhibitor ...
  12. 4qq5 (5,224 bytes)
    14: ...gh combining the salient inhibitory mechanisms of ponatinib and FIIN-2.
  13. 4qqj (4,969 bytes)
    14: ...gh combining the salient inhibitory mechanisms of ponatinib and FIIN-2.
  14. 4qqt (4,937 bytes)
    14: ...gh combining the salient inhibitory mechanisms of ponatinib and FIIN-2.
  15. 4qrc (5,127 bytes)
    2: ...e Kinase Domain of FGF Receptor 4 in Complex with Ponatinib==
    14: ...gh combining the salient inhibitory mechanisms of ponatinib and FIIN-2.
  16. 4twp (8,128 bytes)
    16: ...resistance to all approved ABL1 inhibitors except ponatinib, which has toxicity limitations. Here we combine ...
  17. 4tyg (4,951 bytes)
    14: ...e I-inhibitor Dovitinib and the type II-inhibitor Ponatinib reveal the molecular interactions with different ...
  18. 4tyi (5,019 bytes)
    14: ...e I-inhibitor Dovitinib and the type II-inhibitor Ponatinib reveal the molecular interactions with different ...
  19. 4u0i (7,583 bytes)
    2: ==Crystal structure of KIT in complex with ponatinib==
    16: ...These data strongly support further evaluation of ponatinib in GIST patients.
    18: Ponatinib inhibits polyclonal drug-resistant KIT oncoprotei...
  20. 4uxq (5,037 bytes)
    2: ==FGFR4 in complex with Ponatinib==
    14: ...d with kinetic characterization of the binding of ponatinib and AZD4547 to FGFR1 and FGFR4, sheds light on th...
    16: ...Selectivity: Diverse Binding Modes of AZD4547 and Ponatinib in Complex with FGFR1 and FGFR4.,Tucker JA, Klein...

View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)



Search in namespaces:

Include only Seeded (Automatic) pages - only Human created pages
List redirects
Search for

You may also try
Views
Personal tools